Insights At Scale: The Growing Value Of GenAI In Pharma
Tom Hughes is the founder and CEO of Virtual Science AI.
Sportico on MSN19h
Proposed Pharma Ad Ban May Be a Bitter Pill to Swallow for Sports TV
They dance in kitchens and in meadows frothy with flowers. They dance at weddings. They dance while fireworks bloom in dark ...
Kennedy proposes scrapping public comment on major US health policies
U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. is seeking to eliminate public participation in many of his ...
Recursion Pharmaceuticals, Inc. (RXRX): The Best Performing Pharma Stock So Far in 2025?
We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a ...
Why Royalty Pharma Plc (RPRX) is the Best Performing Pharma Stock So Far in 2025
We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a ...
Contract Pharma8d
Boehringer Ingelheim Names Brian Hilberdink as President, U.S. Human Pharma
Boehringer Ingelheim Pharmaceuticals Inc. has appointed Brian Hilberdink as President, U.S. Human Pharma.
Regeneron Pharmaceuticals, Inc.: Linvoseltamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Multiple Myeloma
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human ...
MAHA caucus member pledges hearings into 'corruption' of a public health sector 'captured by Big Pharma'
Wis., discusses his priorities for the newly created Make America Healthy Again caucus amid the Trump administraton’s mass ...
JD Supra6h
OIG Issues Two Favorable Advisory Opinions for Dental Supply Loyalty Program and Pharmaceutical Manufacturer Sponsor of Genetic Tests
In February 2025, the Office of Inspector General (OIG) for the US Department of Health and Human Services issued favorable advisory opinions ...
Morningstar8d
Boehringer Ingelheim Pharmaceuticals, Inc. Welcomes Brian Hilberdink as President, U.S. Human Pharma
RIDGEFIELD, Conn., Feb. 20, 2025 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. announced today the appointment of Brian Hilberdink as President, U.S ...